U.S. Markets closed

Keryx Biopharmaceuticals, Inc. (KERX)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.46+0.04 (+0.62%)
At close: 4:00PM EDT
People also watch
AEZSCLDXARNAACADOREX
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2017)Next Qtr. (Sep 2017)Current Year (2017)Next Year (2018)
No. of Analysts8887
Avg. Estimate-0.18-0.16-0.69-0.23
Low Estimate-0.21-0.19-0.8-0.32
High Estimate-0.13-0.11-0.52-0.1
Year Ago EPS-0.42-0.39-1.52-0.69
Revenue EstimateCurrent Qtr. (Jun 2017)Next Qtr. (Sep 2017)Current Year (2017)Next Year (2018)
No. of Analysts7788
Avg. Estimate14.51M17.66M64.88M129.02M
Low Estimate13.47M16.8M62.7M95.48M
High Estimate15.42M19M67M185.7M
Year Ago Sales9.29M6.34M31.98M64.88M
Sales Growth (year/est)56.20%178.70%102.90%98.90%
Earnings History6/29/20169/29/201612/30/20163/30/2017
EPS Est.-0.28-0.2-0.25-0.2
EPS Actual-0.42-0.39-0.32-0.21
Difference-0.14-0.19-0.07-0.01
Surprise %-50.00%-95.00%-28.00%-5.00%
EPS TrendCurrent Qtr. (Jun 2017)Next Qtr. (Sep 2017)Current Year (2017)Next Year (2018)
Current Estimate-0.18-0.16-0.69-0.23
7 Days Ago-0.18-0.16-0.69-0.23
30 Days Ago-0.19-0.16-0.66-0.25
60 Days Ago-0.19-0.16-0.67-0.25
90 Days Ago-0.18-0.13-0.61-0.21
EPS RevisionsCurrent Qtr. (Jun 2017)Next Qtr. (Sep 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days3645
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesKERXIndustrySectorS&P 500
Current Qtr.57.10%N/AN/A0.20
Next Qtr.59.00%N/AN/A0.21
Current Year54.60%N/AN/A0.09
Next Year66.70%N/AN/A0.12
Next 5 Years (per annum)116.20%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A